Advertisement
Screener

MERIDIAN BIOSCIENCE, INC. Forms 3, 4 and 5: Stock Options, 2016

MERIDIAN BIOSCIENCE, INC. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 22 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2016-11-16: Reporting owner LUEKE MELISSA; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2016-11-16: Reporting owner ROLIH SUSAN; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2016-11-11: Reporting owner ROLIH SUSAN; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2016-10-03: Reporting owner KRAEUTLER JOHN A; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2016-11-16LUEKE MELISSA
Officer (Exec VP, CFO)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+10,000
10,000 owned after
$16.85
exercise price
2016-11-18
2016-11-16ROLIH SUSAN
Officer (EVP, Global Reg & Quality Syst)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+10,000
10,000 owned after
$16.85
exercise price
2016-11-18
2016-11-11ROLIH SUSAN
Officer (EVP, Reg & Quality Systems)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−15,750
0 owned after
$16.55
exercise price
2016-11-15
2016-10-03KRAEUTLER JOHN A
Director, Officer (Chairman and CEO)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+50,000
50,000 owned after
$19.09
exercise price
2016-10-05
2016-10-03KRAEUTLER JOHN A
Director, Officer (Chairman and CEO)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+50,000
50,000 owned after
$19.09
exercise price
2016-10-05
2016-07-27EBERLY RICHARD
Officer (EVP; Pres, Chief Comm Officer)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+20,000
20,000 owned after
$20.482016-07-29
2016-07-22PHILLIPS DAVID
Director
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−7,500
0 owned after
$18.07
exercise price
2016-07-25
2016-06-13Ellingwood Dwight E
Director
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−3,000
5,500 owned after
$17.34
exercise price
2016-06-14
2016-03-28BALDINI LAWRENCE
Officer (EVP, Pres Global Operations)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+10,000
10,000 owned after
$20.41
exercise price
2016-03-30
2016-03-24Shaughnessy Michael C.
Officer (EVP, Pres Meridian Global Dx)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,000
1,000 owned after
$19.56
exercise price
2016-04-01
2016-03-24ROLIH SUSAN
Officer (EVP, Reg & Quality Systems)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,000
1,000 owned after
$19.56
exercise price
2016-04-01
2016-03-24LUEKE MELISSA
Officer (Exec VP, CFO)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+12,500
12,500 owned after
$19.56
exercise price
2016-04-01
2016-03-24KRAEUTLER JOHN A
Director, Officer (Chairman and CEO)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+15,000
15,000 owned after
$19.56
exercise price
2016-04-01
2016-03-24Elagin Vecheslav A
Officer (EVP, Research & Development)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,000
1,000 owned after
$19.56
exercise price
2016-04-01
2016-03-24BALDINI LAWRENCE
Officer (EVP, Pres Global Operations)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+2,000
2,000 owned after
$19.56
exercise price
2016-04-01
2016-03-24Winslow Amy
Officer (EVP, Pres & CEO of Magellan)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+10,000
10,000 owned after
$19.56
exercise price
2016-03-28
2016-01-27Sazdanoff Catherine
Director
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+8,500
8,500 owned after
$18.64
exercise price
2016-01-28
2016-01-27PHILLIPS DAVID
Director
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+8,500
8,500 owned after
$18.64
exercise price
2016-01-28
2016-01-27McIlwraith John
Director
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+8,500
8,500 owned after
$18.64
exercise price
2016-01-28
2016-01-27Ellingwood Dwight E
Director
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+8,500
8,500 owned after
$18.64
exercise price
2016-01-28
2016-01-27Anderson James M.
Director
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+8,500
8,500 owned after
$18.64
exercise price
2016-01-28
2016-01-07PHILLIPS DAVID
Director
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−5,214
0 owned after
$15.73
exercise price
2016-01-08